Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
261K
-
Shares change
-
-71.5K
-
Total reported value, excl. options
-
$2.48M
-
Value change
-
-$681K
-
Number of buys
-
4
-
Number of sells
-
-4
-
Price
-
$9.51
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q3 2025
9 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q3 2025.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 261K shares
of 53.4M outstanding shares and own 0.49% of the company stock.
Largest 9 shareholders include Simplify Asset Management Inc. (147K shares), LOS ANGELES CAPITAL MANAGEMENT LLC (58.5K shares), COMMONWEALTH EQUITY SERVICES, LLC (25.9K shares), City State Bank (15.5K shares), Voya Investment Management LLC (10.3K shares), CWM, LLC (2.87K shares), MassMutual Private Wealth & Trust, FSB (465 shares), GAMMA Investing LLC (360 shares), and True Wealth Design, LLC (66 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.